European Next-generation Sequencing Services Market, Forecast to 2023

The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-changing Companies • Disruptive Technologies and Business Models Disruptive technologies in NGS are revolutionising the healthcare industry. Launch of high-throughput sequencers has set new service standards, with focus on superior coverage and accuracy. Low-cost and quick turnaround features have amplified NGS uptake as an alternative to traditional methods such as microarray, capillary electrophoresis, and Sanger, propelling the demand for NGS services across areas such as human genetics, plant and animal biotech, agriculture, food and drug safety, and forensics. The European NGS services market is forecast to grow at a CAGR of 15.4% from 2016 to 2023 to reach $605.0 million by 2023. A relatively slow adopter of the technology, Europe now contributes to roughly a third of the global NGS services market size. Government-backed large-scale projects in the region such as the 100,000 Genomes Project of the United Kingdom (UK) and France Genomic Medicine Plan 2025 are poised to bring NGS to the forefront. Industry stakeholders are adapting to current market needs and aligning services with growth opportunities in research and clinical applications. The research service explores current industry trends and market response to the growing sequencing demand. The NGS services market in Europe has been comprehensively studied to understand the core value proposition of game-changing service providers. Industry-wide collaborations, focusing on diversified applications and value-added services, have also been discussed. The study provides an overview of the regional market dynamics focusing on key disruptive factors affecting market growth. The regional market is further segmented and market attractiveness of top countries has been studied. Market size estimations have been provided for Germany, United Kingdom, France, Spain, Italy, and Rest of Europe. Detailed coverage of NGS services market in Germany, UK, and France has been included. Drivers and restraints have been provided for a comprehensive time-bound assessment of the factors influencing the market paradigm. The study also reveals growth opportunities focusing on market needs across diversified application areas. The base year for the study is 2016, with the forecast period being 2017 to 2023. Key Questions this Study will Answer: • How is the market attractiveness for NGS services growing over the years? • What is the future market potential? • How is the $1000 cost per genome milestone distressing market paradigm? • What are the factors driving NGS services demand? • What are the disruptions affecting the value chain equilibrium? • What will be the focal areas on application-based services? • Which are the service lines with maximum growth potential? • How are the new technology trends impacting service providers? • Which are the game-changing companies at work? • What are the strategic levers to stay on the growth trajectory? • How is the changing economic scenario affecting the regional market? • Which are the key markets in Europe?
Published: 2 Feb 2017

European Next-generation Sequencing Services Market, Forecast to 2023

Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth

The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential

Research Scope

  • Revenue Forecasts
  • Regional Market Dynamics
  • Market Share Analysis and Top Countries
  • Key Trends and Growth Opportunities
  • Game-changing Companies
  • Disruptive Technologies and Business Models

Disruptive technologies in NGS are revolutionising the healthcare industry. Launch of high-throughput sequencers has set new service standards, with focus on superior coverage and accuracy. Low-cost and quick turnaround features have amplified NGS uptake as an alternative to traditional methods such as microarray, capillary electrophoresis, and Sanger, propelling the demand for NGS services across areas such as human genetics, plant and animal biotech, agriculture, food and drug safety, and forensics.

The European NGS services market is forecast to grow at a CAGR of 15.4% from 2016 to 2023 to reach $605.0 million by 2023. A relatively slow adopter of the technology, Europe now contributes to roughly a third of the global NGS services market size. Government-backed large-scale projects in the region such as the 100,000 Genomes Project of the United Kingdom (UK) and France Genomic Medicine Plan 2025 are poised to bring NGS to the forefront. Industry stakeholders are adapting to current market needs and aligning services with growth opportunities in research and clinical applications.

The research service explores current industry trends and market response to the growing sequencing demand. The NGS services market in Europe has been comprehensively studied to understand the core value proposition of game-changing service providers. Industry-wide collaborations, focusing on diversified applications and value-added services, have also been discussed.

The study provides an overview of the regional market dynamics focusing on key disruptive factors affecting market growth. The regional market is further segmented and market attractiveness of top countries has been studied. Market size estimations have been provided for Germany, United Kingdom, France, Spain, Italy, and Rest of Europe. Detailed coverage of NGS services market in Germany, UK, and France has been included. Drivers and restraints have been provided for a comprehensive time-bound assessment of the factors influencing the market paradigm. The study also reveals growth opportunities focusing on market needs across diversified application areas.

The base year for the study is 2016, with the forecast period being 2017 to 2023.

Key Questions this Study will Answer

  • How is the market attractiveness for NGS services growing over the years?
  • What is the future market potential?
  • How is the $1000 cost per genome milestone distressing market paradigm?
  • What are the factors driving NGS services demand?
  • What are the disruptions affecting the value chain equilibrium?
  • What will be the focal areas on application-based services?
  • Which are the service lines with maximum growth potential?
  • How are the new technology trends impacting service providers?
  • Which are the game-changing companies at work?
  • What are the strategic levers to stay on the growth trajectory?
  • How is the changing economic scenario affecting the regional market?
  • Which are the key markets in Europe?

Features of this Research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..